MALAT1 reduces the anti-cancer function of NK cells by decreasing the expression of ligands associated with NK cell activation (e.g., MICA/B) and inducing immune checkpoints (e.g., PD-L1), thereby promoting tumor growth and metastasis [92]. Here, CD274 is linked to neoplasm.